TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MRK

Merck & Company Inc

Healthcare · Drug Manufacturers - General

149.50$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Merck & Company Inc (MRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 16,472 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MRK
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5,428 6,317 5,328 6,131 7,687 9,080 9,529 9,862 8,799 7,609 6,765 6,999 6,572 3,392 10,822 12,383 10,022 11,654 7,860 12,421 10,376 6,447 10,922 13,440 10,253 14,109 19,095 13,006 21,468 16,472
927 1,034 1,015 1,145 1,277 1,464 1,488 1,314 1,451 1,708 2,268 1,988 1,631 2,576 7,381 7,427 6,978 6,988 6,691 6,375 5,441 4,637 4,519 3,652 3,625 3,214 3,909 3,872 4,499 5,838
168 211 219 416 509 369 335 276 278 299 300 312 348 417 475 479 541 645 761 820
486 494 454 663 987 1,725 1,595 -398 881 943 -12,589 1,855 3,595 -1,434 1,113 2,078 1,476 2,760 2,023
65 17 -742 -3,454 -1,024 -124 547 489 1,522 1,181 -137 1,356 -3,984 -2,707 930 -766 -4,136 -794 1,824 -268 -2,601 -5,021 -1,553 -2,067 -4,590 -3,839 -2,782 -2,205 -3,667 -6,976
1,197 1,449 1,973 2,561 2,728 2,725 2,370 1,916 1,726 1,403 980 1,011 1,298 1,461 1,678 1,723 1,954 1,548 2,317 1,283 1,614 1,888 2,615 3,473 4,684 4,448 4,388 3,863 3,372 4,112
-1,979 -1,603 -11 -2,817 -3,641 -4,312 -4,011 -4,232 -1,638 2,267 -4,884 -2,810 -1,834 3,156 -3,497 -2,890 -6,805 -3,148 -374 -4,758 -3,210 2,679 4,314 -2,629 -9,443 -16,555 -4,960 -14,083 -7,734 -13,741
1,729 2,040 2,253 2,590 2,798 3,145 3,192 3,250 3,311 3,350 3,323 3,307 3,279 3,479 4,853 4,811 5,236 5,277 5,247 5,117 5,124 5,167 5,172 5,695 6,215 6,610 7,012 7,445 7,840 8,176
-2,493 -3,573 -3,626 -3,582 -3,545 -3,891 -2,091 -2,034 -2,475 -1,015 -1,002 -1,430 -2,725 186 -1,593 -1,921 -2,591 -6,516 -7,703 -4,186 -3,434 -4,014 -9,091 -4,780 -1,281 -840 384 -1,346 -1,306 -5,084
1,781 748 -471 3,164 4,533 -3,931 3,492 -1,307 -1,129 837 1,248 5,011 1,631 -2,251 4,184 2,309 11,377
-3,837 -4,859 -3,921 -3,869 -3,447 -5,071 -5,532 -6,828 -5,591 -3,040 -5,604 -4,866 -5,523 -1,638 -5,441 -6,904 -3,267 -5,990 -15,113 -5,387 -9,044 -10,006 -13,160 -8,861 -2,832 2,593 -9,119 -4,810 -7,032 -1,922
-495 -227 1,481 -584 515 -393 99 -1,042 1,678 6,707 -3,671 -579 -968 4,943 1,589 2,631 -80 2,170 -8,180 1,083 -2,009 -423 1,871 1,967 -1,769 14 4,606 -5,864 6,409 1,372
4,231 4,868 3,355 3,570 4,960 6,355 7,159 7,947 7,073 6,206 5,785 5,988 7,173 1,931 9,791 10,660 8,068 10,106 6,543 11,255 8,762 4,563 8,307 9,967 5,569 9,661 14,707 9,143 18,096 12,360

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?